Notícias e Atividades da Braxia Scientific

Braxia Scientific é uma empresa listada sob o símbolo BRAX (CA).

Veja o organograma con seus 6 executivos principais

Biografias mais buscadas da Braxia Scientific

• Roger McIntyre, Chief Executive Officer & Director
• Olga Cwiek, Director
• Jerry Habuda, Director

Recentes movimentos de executivos em Braxia Scientific

• Peter Rizakos antes Chief Legal Officer, agora é Chief Legal Officer and Director  (Notícia publicada em 19 de novembro de 2024).
• Jerry Habuda, Director, deixou a Companhia  (Notícia publicada em 19 de novembro de 2024).

Criar um alerta
para seguir os movimentos de executivos da Braxia Scientific.

Braxia Scientific possui 2.350 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Johnson & Johnson Innovative Medicine DIA (Estados Unidos).

Popular M&A news in Biotecnologia

• Transcarent and Accolade have merged  (publicado em 9 de abril de 2025)..
• Kashiv BioSciences acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 7 de abril de 2025).
• Atsena Therapeutics acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 4 de abril de 2025).

Outros contatos sugeridos na indústria do Biotecnologia

• Kristina Burow - Director da Scholar Rock
• Steven Gillis - Chairman of the Board da VBI Vaccines
• Ali Behbahani - Non-Executive Director da Adaptimmune Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Braxia Scientific

• Braxia Scientific Reports Fiscal 2023 Financial Results - Braxia Scientific Corp.
• Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic - Braxia Scientific Corp.
• Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America - Braxia Scientific Corp.
• Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual Ketamine Treatments At-Home - Braxia Scientific Corp.
• Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 - Braxia Scientific Corp.
• Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S. Increasing Treatment Access for Mental Health Patients - Braxia Scientific Corp.
• Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with Plans to Expand Across the U.S. - Braxia Scientific Corp.
• Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results - Braxia Scientific Corp.
• Braxia Scientific Bolsters Leadership with Strategic Hires; Adds Chief Information Officer and Global Pharmaceutical Industry Leader as VP R&D and Growth - Braxia Scientific Corp.
• Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond - Braxia Scientific Corp.
• View more press releases Close

Redes sociais sobre Braxia Scientific

• Braxia Scientific na Wikipedia, Google News e Yahoo Finance
• Braxia Scientific na LinkedIn, Twitter e YouTube